Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Does your corporate culture contribute to the problem?

Desjardins RE.

Food Drug Law J. 1997;52(2):169-71. No abstract available.

PMID:
10557554
2.

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

Peck CC, Barr WH, Benet LZ, Collins J, Desjardins RE, Furst DE, Harter JG, Levy G, Ludden T, Rodman JH, et al.

J Clin Pharmacol. 1994 Feb;34(2):111-9. No abstract available.

PMID:
8163710
3.

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

Peck CC, Barr WH, Benet LZ, Collins J, Desjardins RE, Furst DE, Harter JG, Levy G, Ludden T, Rodman JH, et al.

Pharm Res. 1992 Jun;9(6):826-33. No abstract available.

PMID:
1409369
4.

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

Peck CC, Barr WH, Benet LZ, Collins J, Desjardins RE, Furst DE, Harter JG, Levy G, Ludden T, Rodman JH, et al.

J Pharm Sci. 1992 Jun;81(6):605-10. No abstract available.

PMID:
1355792
5.

Opportunities for integration of pharmacokinetics, pharmacodynamics, and toxicokinetics in rational drug development.

Peck CC, Barr WH, Benet LZ, Collins J, Desjardins RE, Furst DE, Harter JG, Levy G, Ludden T, Rodman JH, et al.

Clin Pharmacol Ther. 1992 Apr;51(4):465-73. No abstract available.

PMID:
1563216
6.

Pharmacokinetics and metabolism of allopurinol riboside.

Shapiro TA, Were JB, Danso K, Nelson DJ, Desjardins RE, Pamplin CL 3rd.

Clin Pharmacol Ther. 1991 May;49(5):506-14.

PMID:
2029827
7.

Plasmodium falciparum: induction of resistance to mefloquine in cloned strains by continuous drug exposure in vitro.

Oduola AM, Milhous WK, Weatherly NF, Bowdre JH, Desjardins RE.

Exp Parasitol. 1988 Dec;67(2):354-60.

PMID:
3056740
8.

Importance of oral dosing rate on the hemodynamic and pharmacokinetic profile on nilvadipine.

Cheung WK, Sia LL, Woodward DL, Graveline JF, Desjardins RE, Yacobi A, Silber BM.

J Clin Pharmacol. 1988 Nov;28(11):1001-7.

PMID:
3243913
9.

Pharmacokinetics of cefixime in the young and elderly.

Faulkner RD, Bohaychuk W, Lanc RA, Haynes JD, Desjardins RE, Yacobi A, Silber BM.

J Antimicrob Chemother. 1988 Jun;21(6):787-94.

PMID:
3410802
10.

Plasmodium falciparum: cloning by single-erythrocyte micromanipulation and heterogeneity in vitro.

Oduola AM, Weatherly NF, Bowdre JH, Desjardins RE.

Exp Parasitol. 1988 Jun;66(1):86-95.

PMID:
3284758
11.

Pharmacokinetics of nilvadipine after single oral doses in healthy volunteers.

Cheung WK, Woodward DL, Shin K, Hibberd M, Pearse S, Desjardins RE, Yacobi A, Silber BM.

Int J Clin Pharmacol Res. 1988;8(5):299-305.

PMID:
3229870
12.

The pharmacokinetics of cefixime in the fasted and fed state.

Faulkner RD, Bohaychuk W, Haynes JD, Desjardins RE, Yacobi A, Silber BM.

Eur J Clin Pharmacol. 1988;34(5):525-8.

PMID:
3203716
13.

Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum.

Oduola AM, Milhous WK, Salako LA, Walker O, Desjardins RE.

Lancet. 1987 Dec 5;2(8571):1304-5.

PMID:
2890904
14.

Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state.

Faulkner RD, Bohaychuk W, Desjardins RE, Look ZM, Haynes JD, Weiss AI, Silber BM.

J Clin Pharmacol. 1987 Oct;27(10):807-12.

PMID:
3429686
15.

Safety profile of cefixime.

Tally FP, Desjardins RE, McCarthy EF, Cartwright K.

Pediatr Infect Dis J. 1987 Oct;6(10):976-80.

PMID:
3320926
16.

In vitro activities of and mechanisms of resistance to antifol antimalarial drugs.

Milhous WK, Weatherly NF, Bowdre JH, Desjardins RE.

Antimicrob Agents Chemother. 1985 Apr;27(4):525-30.

17.

Use of non-human plasma for in vitro cultivation and antimalarial drug susceptibility testing of Plasmodium falciparum.

Oduola AM, Alexander BM, Weatherly NF, Bowdre JH, Desjardins RE.

Am J Trop Med Hyg. 1985 Mar;34(2):209-15.

PMID:
3885768
18.

End-tidal exhaled air for the in vitro maintenance of Plasmodium falciparum.

Rogers MD, Weatherly NF, Bowdre JH, Desjardins RE.

Trans R Soc Trop Med Hyg. 1983;77(1):103-5. No abstract available.

PMID:
6344353
19.

Evaluation of the antimalarial activity of the phenanthrenemethanol halofantrine (WR 171,669).

Cosgriff TM, Boudreau EF, Pamplin CL, Doberstyn EB, Desjardins RE, Canfield CJ.

Am J Trop Med Hyg. 1982 Nov;31(6):1075-9.

PMID:
6756175
20.

The method of separate exponentials: a simple aid to devising intravenous drug-loading regimens.

Shand DG, Desjardins RE, Bjornsson TD, Hammill SC, Pritchett EL.

Clin Pharmacol Ther. 1981 Apr;29(4):542-7.

PMID:
7471622
21.

Trypanosoma rhodesiense: semiautomated microtesting for quantitation of antitrypanosomal activity in vitro.

Desjardins RE, Casero RA Jr, Willet GP, Childs GE, Canfield CJ.

Exp Parasitol. 1980 Oct;50(2):260-71. No abstract available.

PMID:
6447614
22.

Activity of 2-acetylpyridine thiosemicarbazones against Trypanosoma rhodesiense in vitro.

Casero RA Jr, Klayman DL, Childs GE, Scovill JP, Desjardins RE.

Antimicrob Agents Chemother. 1980 Aug;18(2):317-22.

23.

Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.

Desjardins RE, Canfield CJ, Haynes JD, Chulay JD.

Antimicrob Agents Chemother. 1979 Dec;16(6):710-8.

24.

Kinetics of a new antimalarial, mefloquine.

Desjardins RE, Pamplin CL 3rd, von Bredow J, Barry KG, Canfield CJ.

Clin Pharmacol Ther. 1979 Sep;26(3):372-9. No abstract available.

PMID:
466930
25.

Metabolic clearance and production rates of 3,3',5-triiodothyronine in hyperthyroid, euthyroid, and hypothyroid subjects.

Smallridge RC, Wartofsky L, Desjardins RE, Burman KD.

J Clin Endocrinol Metab. 1978 Aug;47(2):345-9.

PMID:
263302
26.

Culture of human malaria parasites Plasmodium falciparum.

Haynes JD, Diggs CL, Hines FA, Desjardins RE.

Nature. 1976 Oct 28;263(5580):767-9. No abstract available.

PMID:
825784
27.

Mefloquine (WR 142,490) in the treatment of human malaria.

Trenholme CM, Williams RL, Desjardins RE, Frischer H, Carson PE, Rieckmann KH, Canfield CJ.

Science. 1975 Nov 21;190(4216):792-4.

PMID:
1105787
28.

Prophylactic activity of mefloquine hydrochloride (WR 142490) in drug-resistant malaria.

Rieckmann KH, Trenholme GM, Williams RL, Carson PE, Frischer H, Desjardins RE.

Bull World Health Organ. 1974;51(4):375-7.

Supplemental Content

Loading ...
Support Center